A Phase 3, Open Label, Randomized, Comparative Study of Ticilimumab and Either Dacarbazine or Temozolomide in Patients with Advanced Melanoma

  • Rinehart, John (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/067/31/08